Lung Cancer

Low-Dose Spiral CT Screening and Evaluation of the Solitary Pulmonary Nodule

This article will discuss current tools, approaches, and concerns regarding patient care in this setting.

Lung Cancer Screening: Has Its Time Come?

Lung Cancer

ASCO has endorsed a clinical practice guideline from several associations on when to offer molecular testing for EGFR and ALK mutations in lung cancer patients.

The MAGRIT trial showed no benefit with the recMAGE-A3 + AS15 cancer immunotherapeutic compared with placebo in completely resected, MAGE-A3-positive NSCLC.

NCCN Group 2 high-risk patients to benefit from CT lung screening, study says.

Continuing gefitinib after acquiring resistance to the TKI adds no clinical benefit in patients with EGFR-positive non-small-cell lung cancer, according to trial results presented at the 2014 ESMO Congress.

Adding thoracic radiotherapy to chemotherapy and prophylactic cranial irradiation improved 2-year survival in extensive-stage small-cell lung cancer patients.

Exhaled breath temperature higher than 34 degrees Celsius (93.2 degrees F) could serve as a cutoff value to help diagnose lung cancer, according to a new study.

A new analysis of the NLST showed that both the benefits and harms of low-dose CT screening are slightly greater among patients older than 65 years.


Subscribe to Lung Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.